 The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks Biotech stocks that hit 52-week highs on Feb. 26. Co-Diagnostics Inc NASDAQ: CODX Fate Therapeutics Inc NASDAQ: FATE Gilead Sciences, Inc. NASDAQ: GILD Inspire Medical Systems Inc NYSE: INSP reacted to fourth-quarter results Mersana Therapeutics Inc NASDAQ: MRSN Moderna Inc NASDAQ: MRNA Nevro Corp NYSE: NVRO announced fourth-quarter results Oyster Point Pharma Inc NASDAQ: OYST Regeneron Pharmaceuticals Inc NASDAQ: REGN Revolution Medicines Inc NASDAQ: RVMD Vir Biotechnology Inc NASDAQ: VIR announced a collaboration with WuXi Biologics for the development of antibodies to treat COVID-19 Down In The Dumps Biotech stocks that hit 52-week lows Feb. 26. ABIOMED, Inc. NASDAQ: ABMD Accelerate Diagnostics Inc NASDAQ: AXDX AcelRx Pharmaceuticals Inc NASDAQ: ACRX Acorda Therapeutics Inc NASDAQ: ACOR AngioDynamics, Inc. NASDAQ: ANGO ANCHIANO THERAPS ADR NASDAQ: ANCN Aptevo Therapeutics Inc NASDAQ: APVO Auris Medical Holding Ltd NASDAQ: EARS announced publication of results of a study showing anti-epileptic and anti-convulsive activity of betahistine in a mouse model Blueprint Medicines Corp NASDAQ: BPMC Cumberland Pharmaceuticals, Inc. NASDAQ: CPIX Curis, Inc. NASDAQ: CRIS Enochian Biosciences Inc NASDAQ: ENOB Galectin Therapeutics Inc. 